Clinical Practice Guidelines for the management of atypical Haemolytic Uraemic Syndrome in the United Kingdom
Authors:
- Stephen J WigmoreStephen J Wigmore
- Tim H J GoodshipTGTim H J Goodship
- working party from the Renal Association, the British Committee for Standards in Haematology and the British Transplantation SocietyWSworking party from the Renal Association, the British Committee for Standards in Haematology and the British Transplantation Society
- 14 December 2009
- journal article
- practice guideline
- Published by Wiley in British Journal of Haematology
- Vol. 148 (1) , 37-47
Abstract
Summary: Atypical haemolytic uraemic syndrome (aHUS) is associated with a poor prognosis with regard to survival at presentation, recovery of renal function and transplantation. It is now established that aHUS is a disease of complement dysregulation with mutations in the genes encoding both complement regulators and activators, and autoantibodies against the complement regulator factor H. Identification of the underlying molecular abnormality in an individual patient can now help to guide their future management. In these guidelines we make recommendations for the investigation and management of aHUS patients both at presentation and in the long‐term. We particularly address the role of renal transplantation alone and combined liver‐kidney transplantation.Keywords
This publication has 50 references indexed in Scilit:
- Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndromePediatric Nephrology, 2009
- Mutations in complement C3 predispose to development of atypical hemolytic uremic syndromeBlood, 2008
- Complement and the atypical hemolytic uremic syndrome in childrenPediatric Nephrology, 2008
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Deletion of Complement Factor H–Related Genes CFHR1 and CFHR3 Is Associated with Atypical Hemolytic Uremic SyndromePLOS Genetics, 2007
- Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndromeProceedings of the National Academy of Sciences, 2007
- Atypical Haemolytic Uraemic Syndrome Associated with a Hybrid Complement GenePLOS Medicine, 2006
- Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcomeBlood, 2006
- An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutationsHuman Mutation, 2005
- Cobalamin C defect associated with hemolytic-uremic syndromeThe Journal of Pediatrics, 1992